Platycodin D and voluntary running synergistically ameliorate memory deficits in 5 x FAD mice via mediating neuromodulation and neuroinflammation.

Autor:	Junxin Liu, Jiahui Jiang, Chuantong He, Longjian Zhou, Yi Zhang, Shuai Zhao, Zhiyou Yang
Předmět:	NEUROPROTECTIVE agents ELDER care ALZHEIMER'S disease RESEARCH funding EXERCISE DATA analysis RUNNING EXERCISE therapy NEUROGLIA NEURONS ENZYME-linked immunosorbent assay KRUSKAL-Wallis Test PLANT roots NEUROINFLAMMATION DESCRIPTIVE statistics QUANTITATIVE research NEURODEGENERATION PLANT extracts MICE TEMPORAL lobe IMMUNOHISTOCHEMISTRY COMBINED modality therapy ANIMAL experimentation LIQUID chromatography STATISTICS CYTOKINES DEMENTIA HIPPOCAMPUS (Brain) DATA analysis software MEMORY disorders NEUROTRANSMITTERS HUMAN locomotion COGNITION
Zdroj:	Frontiers in Aging Neuroscience; 2024, p1-14, 14p
Abstrakt:	Introduction: Alzheimer's disease (AD) is the leading cause of dementia, and currently, no effective treatments are available to reverse or halt its progression in clinical practice. Although a plethora of studies have highlighted the benefits of physical exercise in combating AD, elder individuals often have limited exercise capacity. Therefore, mild physical exercise and nutritional interventions represent potential strategies for preventing and mitigating neurodegenerative diseases. Our research, along with other studies, have demonstrated that platycodin D (PD) or its metabolite, platycodigenin, derived from the medicinal plant Platycodon grandiflorus, exerts neuroprotective effects against amyloid b (Ab)-induced neuroinflammation. However, the combined effects of PD and physical exercise on alleviating AD have yet to be explored. The current study aimed to investigate whether combined therapy could synergistically ameliorate memory deficits and AD pathology in 5 FAD mice. Methods: Five-month-old 5 x FAD mice were randomly assigned to four groups, and received either PD (5 mg/kg/day, p.o.), voluntary running, or a combination of both for 47 days. Nest building test, locomotion test, and Morris water maze test were used to evaluate the cognitive function. Immunohistochemical and ELISA analysis was performed to determine Ab build-up, microglia and astrocytes hyperactivation, and survival neurons in the hippocampus and perirhinal cortex. Real-time quantitative PCR analysis was used to assess the polarization of microglia and astrocytes. HPLC analysis was performed to measure monoamine neurotransmitters in the hippocampus. Results and discussion: The combination of PD and voluntary running synergistically restored nest-building behavior, alleviated recognition and spatial memory deficits, and showed superior effects compared to monotherapy. In addition, the PD and voluntary running combination reduced Ab build-up, decreased hyperactivation of microglia and astrocytes in the hippocampus and perirhinal cortex, promoted the polarization of inflammatory M1 microglia and reactive astrocytes toward beneficial phenotypes, and lowered systemic circulating pro-inflammatory cytokines while increasing anti-inflammatory cytokines in 5 FAD mice. Furthermore, combined therapy effectively protected neurons and increased levels of 5-hydroxytryptamine (5-HT) and dopamine (DA) in the hippocampus of 5 FAD mice. In conclusion, the combination of PD and voluntary running holds great potential as a treatment for AD, offering promise for delaying onset or progression of AD. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu